Governance
begin with JW’s transparent governance structure.
JW invests more than 14% of its revenue in R&D, creating value by advancing human health through innovation.
We place ethical and responsible management at the top of our priorities, driving sustainable future growth.
In particular, JW’s proprietary R&D platform,
which extends from original medicines based on solid technological capabilities to innovative new drugs,
is the outcome of transparent decision-making and objective, accountable management.
This proves JW’s advanced governance system, including comprehensive risk management.
JW will continue to pursue sound management that earns the trust of customers and shareholders,
and grow into a leading global healthcare company representing Korea.
Corporate Governance Policies
| No. | Title | Attachment |
|---|---|---|
| 1 | Articles of Incorporation | Download |
| 2 | Board of Directors Regulations | Download |
| 3 | Audit Committee Regulations | Download |